# Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects

> **NCT01359605** · PHASE1 · COMPLETED · sponsor: **Anthera Pharmaceuticals** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** varespladib methyl

## Key facts

- **NCT ID:** NCT01359605
- **Lead sponsor:** Anthera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2011-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01359605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01359605, "Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT01359605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*